Patient Resources

Resources for your patients

Download to support your patients with their treatment experience.

RYBREVANT® + LAZCLUZE™ Patient Brochure–1L EGFR+

A general guide to RYBREVANT® + LAZCLUZE™ for the first treatment of NSCLC with common EGFR+ mutations.

Patient Wallet Card

Streamlined treatment information card for patients on the go.

Patient Treatment Journal

A notebook designed for an individual to track their treatment plan and journey.

Patient Affordability Options for RYBREVANT® + LAZCLUZE™

Discover options that may help make RYBREVANT® in combination with LAZCLUZE™ more affordable for your patients. Download this resource to help your patients learn about cost support options.

Patient Affordability Options for RYBREVANT®

Discover options that may help make RYBREVANT® more affordable for your patients. Download this resource to help your patients learn more about cost support options.

RYBREVANT® + Chemotherapy Patient Brochure

A general guide to RYBREVANT® + chemotherapy for the second treatment of NSCLC with EGFR exon 19 deletions or L858R mutations and the first treatment of NSCLC with EGFR exon 20 insertion mutations.


Once you have made the clinical decision to prescribe a RYBREVANT® regimen, Johnson & Johnson has resources to help you support your patients.

RybWithMe
RYBREVANT withMe logo

J&J withMe is your single source for access, affordability, and treatment support programs from Johnson & Johnson.

Your patients will be connected to RYBREVANT withMe to get:

  • Cost support options regardless of their insurance type
  • Free, personalized 1-on-1 support from a Care Navigator
  • Resources and community connections

After signing up, patients will receive a free Patient Starter Kit with resources to help them start RYBREVANT® treatment

Your patient can get connected to RYBREVANT withMe by visiting RYBREVANTwithMe.com OR by calling 833-JNJ-WMe 1 (833-565-9631), Monday through Friday, 8:00 AM–8:00 PM ET

The patient support resources provided by J&J withMe are not intended to provide medical advice, replace a treatment plan from the patient's doctor or nurse, provide case management services, or serve as a reason to prescribe RYBREVANT®.